DavidAdamWeinsteinMDMMSc

Pediatric Endocrinology • Villanova, PA

Founder, Weinstein Rare Disease and Clinical Development Consulting

Join to view full profile

Dr. Weinstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weinstein's full profile

Already have an account?

Office
618 Newtown Road
Villanova, PA 19085
Phone+1 352-226-1961

Summary

Dr. David Weinstein is a pediatric endocrinologist in Villanova, PA. He received his medical degree from Harvard Medical School and has been in practice 30 years. He is experienced in glycogen storage diseases, gene therapy, and hypoglycemia. In addition to being in the academic world for 30 years, he has served as SVP at Passage Bio and the interim CMO at Grace Science. In 1989, he was named as one of the inaugural Goldwater Scholars. He is a former Jan Albrecht Award winner from the American Association for the Study of Liver Diseases, and he was the George Sacher Award winner from the Gerontological Society of America. In 2013, Dr. Weinstein was knighted in Poland and honored with the Order of the Smile international humanitarian award.

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Endocrinology, 1998 - 2001
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1994 - 1998
Harvard Medical SchoolClass of 1994

Certifications & Licensure

CT State Medical License 2016 - 2021
FL State Medical License 2005 - 2018

Publications & Presentations

PubMed

14 citations
Complex patterns of inheritance, including synergistic heterozygosity, in inborn errors of metabolism : Implications for precision medicine driven diagnosis and treatment
Jerry Vockley, Steven F. Dobrowolski, Georgianne L. Arnold, Ruben Bonilla Guerrero, Terry G J Derks
Molecular Genetics and Metabolism. 2019-09-01
1 citations
Fasting ketone levels vary by age: implications for differentiating physiologic from pathologic ketotic hypoglycemia.
Komalben Parmar, Maua Mosha, David A Weinstein, Rebecca Riba-Wolman
Journal of Pediatric Endocrinology & Metabolism. 2023-07-26
13 citations
Towards enhanced understanding of idiopathic ketotic hypoglycemia: a literature review and introduction of the patient organization, Ketotic Hypoglycemia International.
Danielle Drachmann, Erica Hoffmann, Austin Carrigg, Beccie Davis-Yates, Valerie Weaver
Orphanet Journal of Rare Diseases. 2021-04-13

Journal Articles

Gene therapy for treatment of monogenic neurodegenerative diseases.
Anderson KM, McNeil DE, Weinstein DA, Romano G., Neurology Rev (Rare Neurological Disease Supplement), 2021
Inflammatory bowel disease in glycogen storage disease type Ia: a case series.
Lawrence NT, Chengsupanimit T, Brown LM, Derks TGJ, Smit GP, Weinstein DA., J Pediatr Gastroenterol Nutrit., 2017
Late Diagnosis of Fanconi-Bickel Syndrome: Challenges with the diagnosis and literature review.
Gupta N, Nambam B, Weinstein DA, Shoemaker L, J Inherit Errors Metabol Scr, 2016
Microbial profile of supragingival and subgingival plaque of patients with glycogen storage disease
Brinkman CE, Adewumi AO, Gong Y, Huang H, Weinstein DA, Nascimento MM, Shaddox LM., J Inherit Errors Metabol Scr., 2016
Glycogen storage diseases: diagnosis, treatment, and outcome.
Chen MA, Weinstein DA., Transl Sci Rare Dis., 2016
Evaluation of glycogen storage disease as a cause of ketotic hypoglycemia in children.
Brown LM, Corrado MM, van der Ende RM, Derks TG, Chen MA, Siegel S, Hoyt K, Correia CE, Lumpkin C, Flanagan TB, Carreras CT, Weinstein DA., J Inherit Metab Dis., 2015
Safety and efficacy of long-term use of extended release cornstarch therapy for glycogen storage disease types 0, III, VI, and IX.
Ross KM, Brown LM, Corrado MM, Chengsupanimit T, Curry LM, Ferrecchia IA, Porras LY, Mathew JT, Dambska M, Weinstein DA., J Nutri Therap, 2015
In vitro digestion of starches in a dynamic gastrointestinal model: an innovative study to optimize dietary management of patients with hepatic glycogen storage diseases.
Nalin T, Venema K, Weinstein DA, de Souza CF, Perry ID, van Wandelen MT, van Rijn M, Smit GP, Schwartz IV, Derks TG., J Inherit Metab Dis, 2015
Disordered eating and body esteem among individuals with glycogen storage disease.
Flanagan TB, Sutton JA, Brown LM, Weinstein DA, Merlo LJ., JIMD Rep, 2015
Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I
Beegle RD, Brown LM, Weinstein DA, JIMD Rep, 2015
Re-evaluating “Transitional Neonatal Hypoglycemia”: mechanism and implications for management
Stanley CA, Rozance PJ, Thornton PS, De Leon DD, Harris D, Haymond MW, Hussain K, Levitsky LL, Murad MH, Simmons RA, Sperling MA, Weinstein DA, White NH, Wolfsdorf JI., J Pediatr, 2015
Pediatric Endocrine Society and European Society for Pediatric Endocrinology. Recommendations from the Pediatric Endocrine Society for evaluation and management of pe...
Thornton PS, Stanley CA, De Leon DD, Harris DL, Haymond MW, Hussain K, Levitsky LL, Murad MH, Rozance PJ, Simmons RA, Sperling MA, Weinstein DA, White NH, Wolfsdorf JI., J Pediatr, 2015
Vitamin D supplementation and the risk of toxicity in pediatrics: a review of current literature.
Vogiatzi MG, Jacobson-Dickman E, DeBoer MD, and the Drugs and Therapeutics Committee of the Pediatric Endocrine Society (Fechner P, Kapadia C, Miller B, Myers S, Nebes..., J Clin Endocrinol Metab, 2014
Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.
Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, Chung WK, Dagli AI, Dale D, Koeberl D, Somers MJ, Wechsler SB, Weinstein DA, Wolfsdorf JI, Watson MS., Genet Med., 2014
Pregnancy in women with glycogen storage disease Ia and Ib.
Ferrecchia IA, Guenette G, Potocik, EA, Weinstein DA., J Perinatal Neonatal Nurs, 2014
Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
Chiu LY, Kishnani P, Chuang TP, Tang CY, Liu CY, Bali D, Koeberl D, Austin S, Boyette K, Weinstein DA, Murphy E, Yao A, Chen YT, Li LH., J Gastroenterol., 2014
Thyroid storm following radioactive iodine (RAI) therapy for pediatric Graves Disease.
Rohrs HJ 3rd, Silverstein JH, Weinstein DA, Amdur RJ, Haller MJ., Am J Med Case Rep, 2014
Hypoglycemia in Prader-Willi Syndrome.
Harrington R, Weinstein DA, Miller JL., Am J Med Genet A., 2014
Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib.
Jun HS, Weinstein DA, Lee YM, Mansfield BC, Chou JY., Blood, 2014
Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene.
Bali DS, Goldstein JL, Fredrickson K, Rehder C, Boney A, Austin S, Weinstein DA, Lutz R, Boneh A, Kishnani PS., Mol Genet Metab, 2014
Neutropenia in glycogen storage disease 1b (GSD1b).
Dale DC, Bolyard AA, Marrero TM, Kelley ML, Phan L, Boxer LA, Kishnani PS, Austin S, Kurtzberg J, Weinstein DA., Blood, 2013
Aggressive therapy improves cirrhosis in glycogen storage disease type IX.
Tsilianidis LA, Fiske LM, Siegel S, Lumpkin C, Hoyt K, Wasserstein M, Weinstein DA., Mol Genet Metab, 2013
Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib
Wang DQ, Carreras CT, Fiske LM, Austin S, Boree D, Kishnani PS, Weinstein DA., Genet Med., 2012
Glycogen storage disease type Ia: Linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.
Sever S, Weinstein DA, Wolfsdorf JI, Gedik R, Schaefer EJ., J Clin Lipidol., 2012
Bone mineral density in glycogen storage disease type Ia and Ib.
Minarich LA, Kirpich A, Fiske LM, Weinstein DA., Genet Med., 2012
Join now to see all